Number of centromeric signals in micronuclei and mechanisms of aneuploidy

Toxicology Letters

Volumn 166, Issue 1, 2006, Pages 1-10

  Iarmarcovai, G ^a   Botta, A ^a   Orsiere T ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Centrosome; Chromosome instability; Chromosome loss; Cytokinesis block micronucleus assay; Fluorescent in situ hybridisation

Indexed keywords

BIOLOGICAL MARKER; MUTAGENIC AGENT;

ANEUPLOIDY; CANCER DIAGNOSIS; CARCINOGENESIS; CELL CYCLE; CELL NUCLEUS; CENTROMERE; CENTROSOME; CHROMOSOMAL INSTABILITY; CHROMOSOME DAMAGE; CYTOKINESIS; DNA PROBE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC POLYMORPHISM; GENOME; GENOTOXICITY; HUMAN; LYMPHOCYTE; MICRONUCLEUS; OCCUPATIONAL EXPOSURE; ORGANIZATION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SEPARATION TECHNIQUE; SIGNAL TRANSDUCTION; SPINDLE CELL;

ANEUPLOIDY; CENTROMERE; DNA PROBES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; NEOPLASMS;

EID: 33747779709     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2006.05.015     Document Type: Review

References (59)

1. Aardema M.J., Albertini S., Arni P., Henderson L.M., Kirsch-Volders M., Mackay J.M., Sarrif A.M., Stringer D.A., and Taalman R.D. Aneuploidy: a report of an ECETOC task force. Mutat. Res. 410 (1998) 3-79
2. Andrianopoulos C., Stefanou G., and Demopoulos N.A. Genotoxicity of hydrochlorothiazide in cultured human lymphocytes. I. Evaluation of chromosome delay and chromosome breakage. Environ. Mol. Mutagen. 47 (2006) 169-178
3. Baciuchka-Palmaro M., Orsière T., Duffaut F., Sari-Minodier I., Pompili J., Bellon L., De Méo M., Digue L., Favre R., and Botta A. Acentromeric micronuclei are increased in peripheral blood lymphocytes of untreated cancer patients. Mutat. Res. 520 (2002) 189-198
4. Bakou K., Stephanou G., Andrianoupoulos C., and Demopoulos N.A. Spontaneous and spindle poison-induced micronuclei and chromosome non-disjunction in cytokinesis-blocked lymphocytes from two age groups of women. Mutagenesis 17 (2002) 233-239
5. Bolt H.M., Foth H., Hengstler J.G., and Degen G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicol. Lett. 151 (2004) 29-41
6. Bonassi S., Hagmar L., Strömberg U., Montagud A.H., Tinnerberg H., Forni A., Heikkilä P., Wanders S., Wilhardt P., Hansteen I.L., Knudsen L.E., and Norppa H. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens European Study Group on Cytogenetic Biomarkers and Health. Cancer Res. 60 (2000) 1619-1625
7. Bonassi S., Znaor A., Norppa H., and Hagmar L. Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective. Cytogenet. Genome Res. 104 (2004) 376-382
8. Bonassi S., Ugolini D., Kirsch-Volders M., Stromberg U., Vermeulen R., and Tucker J.D. Human population studies with cytogenetic biomarkers: review of the literature and future prospectives. Environ. Mol. Mutagen. 45 (2005) 258-270
9. Boveri T. Zur Frage der Entstehung Maligner Tumoren (1929), Fischer Verlag, Jena (English translation by M. Boveri reprinted as 'The Origin of Malignant Tumors' Baltimore Williams and Wilkins Co.)
10. Brunet S., and Vernos I. Chromosome motors on the move from motion to spindle checkpoint activity. EMBO Rep. 2 (2001) 669-673
11. Catalan J., Autio K., Wessman M., Lindholm C., Knuutila S., Sorsa M., and Norppa H. Age-associated micronuclei containing centromeres and the X chromosome in lymphocytes of women. Cytogenet. Cell Genet. 68 (1995) 11-16
12. Catalan J., Autio K., Kuosma E., and Norppa H. Age-dependent inclusion of sex chromosomes in lymphocyte micronuclei of man. Am. J. Hum. Genet. 63 (1998) 1464-1472
13. Catalan J., Falck G.C., and Norppa H. The X chromosome frequently lags behind in female lymphocyte anaphase. Am. J. Hum. Genet. 66 (2000) 669-687
14. D'Assoro A.B., Lingle W.L., and Salisbury J.L. Centrosome amplification and the development of cancer. Oncogene 21 (2002) 6146-6153
15. Dey P. Aneuploidy and malignancy: an unsolved equation. J. Clin. Pathol. 57 (2004) 1245-1249
16. Digue L., Orsière T., De Méo M., Mattéi M.G., Depetris D., Duffaud F., Favre R., and Botta A. Evaluation of the genotoxic activity of paclitaxel by the in vitro micronucleus test in combination with fluorescent in situ hybridization of a DNA centromeric probe and the alkaline single cell gel electrophoresis technique (comet assay) in human T-lymphocytes. Environ. Mol. Mutagen. 34 (1999) 269-278
17. Duesberg P., Fabarius A., and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56 (2004) 65-81
18. Eastmond D.A., Schuler M., and Rupa D.S. Advantages and limitations of using fluorescence in situ hybridization for the detection of aneuploidy in interphase human cells. Mutat. Res. 348 (1995) 153-162
19. Fauth E., and Zankl H. Comparison of spontaneous and idoxuridine-induced micronuclei by chromosome painting. Mutat. Res. 440 (1999) 147-156
20. Fenech M. The in vitro micronucleus technique. Mutat. Res. 445 (2000) 81-95
21. Fenech M. Chromosomal biomarkers of genomic instability relevant to cancer. Drug Discov. Today 7 (2002) 1128-1137
22. Fenech M. The genome health clinic and genome health nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Mutagenesis 20 (2005) 255-269
23. Fenech M., and Morley A.A. Measurement of micronuclei in lymphocytes. Mutat. Res. 147 (1985) 29-36
24. Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 230 (2005) 6-19
25. Hande M.P., Boei J.J., and Natarajan A.T. Induction and persistence of cytogenetic damage in mouse splenocytes following whole-body X-irradiation analysed by fluorescence in situ hybridisation. III. Chromosome malsegregation/aneuploidy. Mutagenesis 12 (1996) 125-131
26. Harkönen K. Pesticides and the induction of aneuploidy in human sperm. Cytogenet. Genome Res. 111 (2005) 378-383
27. Hollander M.C., and Fornace Jr. A.J. Genomic instability, centrosome amplification, cell cycle checkpoints and Gadd45a. Oncogene 21 (2002) 6228-6233
28. Holmes A.L., Wise S.S., Sandwick S.J., Lingle W.L., Negron V.C., Thompson W.D., and Wise Sr. J.P. Chronic exposure to lead chromate causes centrosome abnormalities and aneuploidy in human lung cells. Cancer Res. 66 (2006) 4041-4048
29. Iarmarcovai G., Sari-Minodier I., Orsière T., De Méo M., Gallice P., Bideau C., Iniesta D., Pompili J., Bergé-Lefranc J.L., and Botta A. A combined analysis of XRCC1, XRCC3 GSTM1 and GSTT1 polymorphisms and centromere content of micronuclei in welders. Mutagenesis 21 (2006) 159-165
30. Izzo M., Antoccia A., Degrassi F., and Tanzarella C. Immunofluorescence analysis of diazepam-induced mitotic apparatus anomalies and chromosome loss in Chinese hamster cells. Mutagenesis 13 (1998) 445-451
31. Kearns W.G., Yamaguchi H., Young N.S., and Liu J.M. Centrosome amplification and aneuploidy in bone marrow failure patients. Genes Chromosomes Cancer 40 (2004) 329-333
32. Kirsch-Volders M., Vanhauwaert A., De Boeck M., and Decordier I. Importance of detecting numerical versus structural chromosome aberrations. Mutat. Res. 504 (2002) 137-148
33. Kirsch-Volders M., Vanhauwaert A., Eichenlaub-Ritter U., and Decordier I. Indirect mechanisms of genotoxicity. Toxicol. Lett. 140/141 (2003) 63-74
34. Kyrtopoulos S.A. Biomarkers in environmental carcinogenesis research: striving for a new momentum. Toxicol. Lett. 162 (2006) 3-15
35. Leach N.T., and Jackson-Cook C. The application of spectral karyotyping (SKY) and fluorescent in situ hybridization (FISH) technology to determine the chromosomal content(s) of micronuclei. Mutat. Res. 495 (2001) 11-19
36. Leach N.T., and Jackson-Cook C. Micronuclei with multiple copies of the X chromosome: do chromosomes replicate in micronuclei?. Mutat Res. 554 (2004) 89-94
37. Leach N.T., Rehder C., Jensen K., Holt S., and Jackson-Cook C. Human chromosomes with shorter telomeres and large heterochromatin regions have a higher frequency of acquired somatic cell aneuploidy. Mech. Ageing Dev. 125 (2004) 563-573
38. Lindh A.R., Rafii S., Schultz N., Cox A., and Helleday T. Mitotic defects in XRCC3 variants T241M and D213N and their relation to cancer susceptibility. Hum. Mol. Genet. 15 (2006) 1217-1224
39. Lingle W.L., Lutz W.H., Ingle J.N., Maihle N.J., and Salisbury J.L. Centrosome hypertrophy in human breast tumors: implications for genomic stability and cell polarity. Proc. Natl. Acad. Sci. USA 95 (1998) 2950-2955
40. Mateuca R., Aka P.V., De Boeck M., Hauspie R., Kirsh-Volders M., and Lison D. Influence of hOGG1 XRCC1 and XRCC3 genotypes on biomarkers of genotoxicity in workers exposed to cobalt or hard metal dusts. Toxicol. Lett. 156 (2005) 277-288
41. Migliore L., Bocciardi R., Macri C., and Lo Jacono F. Cytogenetic damage induced in human lymphocytes by four vanadium compounds and micronucleus analysis by fluorescence in situ hybridization with a centromeric probe. Mutat. Res. 319 (1993) 205-213
42. Montagna C., Andrechek E.R., Padilla-Nash H., Muller W.J., and Ried T. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene 21 (2002) 890-898
43. Nigg E.A. Centrosome aberrations: cause or consequence of cancer progression?. Nature Rev. Cancer 2 (2002) 815-825
44. Norppa H. Cytogenetic biomarkers and genetic polymorphisms. Toxicol. Lett. 149 (2004) 309-334
45. Norppa H., and Falck G.C. What do human micronuclei contain?. Mutagenesis 18 (2003) 221-233
46. Norppa H., Renzi L., and Lindholm C. Detection of whole chromosomes in micronuclei of cytokinesis-blocked human lymphocytes by antikinetochore staining and in situ hybridization. Mutagenesis 8 (1993) 519-525
47. Ochi T. Methylmercury, but not inorganic mercury, causes abnormality of centrosome integrity (multiple foci of gamma-tubulin), multipolar spindles and multinucleated cells without microtubule disruption in cultured Chinese hamster V79 cells. Toxicology 175 (2002) 111-121
48. Orsière T., Sari-Minodier I., Iarmarcovai G., and Botta A. Genotoxic risk assessment of pathology and anatomy laboratory workers exposed to formaldehyde using personal air sampling and DNA damage analysis in peripheral lymphocytes. Mutat. Res. 605 (2006) 30-41
49. Parry J.M., Parry E.M., Bourner R., Doherty A., Ellard S., O'Donovan J., Hoebee B., De Stoppelaar J.M., Mohn G.R., Onfelt A., Renglin A., Schultz N., Söderpalm-Berndes C., Jensen K.G., Kirsch-Volders M., Elhajouji A., Van Hummelen P., Degrassi F., Antoccia A., Cimini D., Izzo M., Tanzarella C., Adler I.D., Kliesch U., Schriever-Schwemmer G., Gasser P., Crebelli R., Carere A., Andreoli C., Benigni R., Leopardi P., Marcon F., Zinjo Z., Natarajan A.T., Boei J.J.W.A.A., Kappas A., Voutsinas G., Zarani F.E., Patrinelli A., Pachierotti F., Tiveron C., and Hess P. The detection and evaluation of aneugenic chemicals. Mutat. Res. 353 (1996) 11-46
50. Parry E.M., Parry J.M., Corso C., Doherty A., Haddad F., Hermine T.F., Johnson G., Kayani M., Quick E., Warr T., and Williamson J. Detection and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis 17 (2002) 509-521
51. Pfuhler S., and Wolf H.U. Effects of the formaldehyde releasing preservatives dimethylol urea and diazolidinyl urea in several short-term genotoxicity tests. Mutat. Res. 514 (2002) 133-146
52. Sato N., Mizumoto K., and Tanaka M. Radiation therapy and centrosome anomalies in pancreatic cancer. In: Nigg E.A. (Ed). Centrosomes in Development and Disease (2004), Wiley-VCH Verlag GmbH and Co. KGaA, Weinheim 337-352
53. Saunders W.S., Shuster M., Huang X., Gharaibeh B., Enyenihi A.H., Petersen I., and Gollin S.M. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc. Natl. Acad. Sci. USA 97 (2000) 303-308
54. Schuler M., Muehlbauer P., Guzzie P., and Eastmond D.A. Noscapine hydrochloride-induced numerical aberrations in cultured human lymphocytes: a comparison of FISH detection methods and multiple end-points. Mutagenesis 18 (2003) 235-242
55. Shi Q., and King R.W. Chromosome nondisjunction yields tetraploid rather than aneuploid cells in human cell lines. Nature 437 (2005) 1038-1042
56. Storchova Z., and Pellman D. From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5 (2004) 45-54
57. Yamamoto Y., Matsuyama H., Furuya T., Oga A., Yoshihiro S., Okuda M., Kawauchi S., Sasaki K., and Naito K. Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Clin. Cancer Res. 10 (2004) 6449-6455
58. Yuen K.W., Montpetit B., and Hieter P. The kinetochore and cancer: what's the connection?. Curr Opin. Cell. Biol. 17 (2005) 576-582
59. Zhu J., Abbruzzese J.L., Izzo J., Hittelman W.N., and Li D. AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells. Cancer Genet. Cytogenet. 159 (2005) 10-17